VaxCell Biotherapeutics Co., Ltd.
The Better life with Anti-cancer immunotherapy
Korea South
7 employees
Post Ipo Equity
Biopharma, Biotechnology +2
General Information
Get notified when VaxCell Biotherapeutics Co., Ltd. moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track VaxCell Biotherapeutics Co., Ltd.
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
Korea South Market
Biopharma
About VaxCell Biotherapeutics Co., Ltd.
Taxonomy: Pharmaceuticals, Immunotherapy, Cancer Treatment, Cellular Therapy, Medical Technology, Innovation, Clinical Research, NK Cells, CAR-T Cell Therapy, Cell Therapy, Biotherapeutics, Clinical Trials, Research & Development
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Post-IPO Equity | •••••• | 2 |
|
01 Jan 2021 |
VaxCell Biotherapeutics Co., Ltd. Alternatives & Competitors
KaliVir Immunotherapeutics was founded in 2019 to pioneer a unique and novel approach to cancer trea...
-logo.jpg "Denvax"){kind=logo}
Denvax, spearheaded by Dr. Sharmin Yaqin & Dr. Jamal A Khan, offers a personalized cancer treatment...
Immuno-Oncology and Immuno-Inflammation - Breakthrough Immuno-Science for Patients
FAQ About VaxCell Biotherapeutics Co., Ltd.
Don't just browse. Track.
Signal Tracker monitors VaxCell Biotherapeutics Co., Ltd. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.
